Advertisement
CRL vs LUCD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and LUCD is a Hold.
CRL sees its Stochastic Oscillator climbs out of oversold territory
On November 09, 2026, the Stochastic Oscillator for CRL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In 41 of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +12.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 200 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 147 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for CRL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRL as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for CRL turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 36 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 1 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (67.298). P/E Ratio (-70.170) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
LUCD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for LUCD turned positive on October 27, 2026. Looking at past instances where LUCD's MACD turned positive, the stock continued to rise in 43 of 47 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LUCD's RSI Oscillator exited the oversold zone, 31 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +7.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in 199 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In 75 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for LUCD entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.955) is normal, around the industry mean (4.142). P/E Ratio (-0.971) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (21.645) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. LUCD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CRL | ||
|---|---|---|
OUTLOOK RATING 1..100 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 1 | |
P/E GROWTH RATING 1..100 | 91 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CRL | LUCD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 72% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 83% |
| Advances ODDS (%) | 3 days ago 70% | 3 days ago 81% |
| Declines ODDS (%) | 7 days ago 69% | 15 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 64% | 2 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRL’s FA Score shows that 2 FA rating(s) are green while LUCD’s FA Score has 1 green FA rating(s).
- CRL’s FA Score: 2 green, 3 red.
- LUCD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRL’s TA Score shows that 3 TA indicator(s) are bullish while LUCD’s TA Score has 5 bullish TA indicator(s).
- CRL’s TA Score: 3 bullish, 5 bearish.
- LUCD’s TA Score: 5 bullish, 3 bearish.
Price Growth
CRL (@Medical Specialties) experienced а -1.73% price change this week, while LUCD (@Medical/Nursing Services) price change was -2.20% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
CRL is expected to report earnings on Feb 24, 2027.
LUCD is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Medical Specialties (-4.92% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CRL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To CRL | 1D Price Change % | ||
|---|---|---|---|---|
| CRL | 100% | -2.13% | ||
| RGEN - CRL | 56% Loosely correlated | -2.77% | ||
| AZTA - CRL | 56% Loosely correlated | -1.15% | ||
| MEDP - CRL | 56% Loosely correlated | -1.25% | ||
| BRKR - CRL | 53% Loosely correlated | -6.46% | ||
| SHC - CRL | 52% Loosely correlated | -1.03% | ||
More | ||||
LUCD and
Correlation & Price change
A.I.dvisor tells us that LUCD and FEMY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and FEMY's prices will move in lockstep.
| Ticker / NAME | Correlation To LUCD | 1D Price Change % | ||
|---|---|---|---|---|
| LUCD | 100% | -4.19% | ||
| FEMY - LUCD | 30% Poorly correlated | +0.70% | ||
| CNMD - LUCD | 27% Poorly correlated | -1.41% | ||
| CRL - LUCD | 27% Poorly correlated | -2.13% | ||
| BBNX - LUCD | 27% Poorly correlated | -2.54% | ||
| ELMD - LUCD | 26% Poorly correlated | +0.44% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBY | 8.21 | -0.02 | -0.24% |
| YieldMax META Option Income Strategy ETF (FBY) | |||
| XSPC | 18.16 | -0.07 | -0.38% |
| VegaShares Space & AI ETF (XSPC) | |||
| ESLG | 27.48 | -0.12 | -0.42% |
| Eventide Large Cap Growth ETF (ESLG) | |||
| PMBS | 47.18 | -0.43 | -0.90% |
| PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund (PMBS) | |||
| NVDU | 76.65 | -9.43 | -10.95% |
| Direxion Daily NVDA Bull 2X ETF (NVDU) | |||